Description
Atosiban is an antagonist at oxytocin and vasopressin receptors, exhibiting tocolytic activity. Atosiban is clinically used to decrease uterine contractility in the prevention of preterm birth.
Product Unit Size | Cost | Quantity | Stock |
---|
Atosiban is an antagonist at oxytocin and vasopressin receptors, exhibiting tocolytic activity. Atosiban is clinically used to decrease uterine contractility in the prevention of preterm birth.
Cas No. | 914453-95-5 |
---|---|
Purity | ≥95% |
Formula | C43H67N11O12S2 |
Formula Wt. | 994.2 |
IUPAC Name | acetic acid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2- yl]-1-[(4R,7S,13S, 16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl) methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8, 11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide |
Solubility | Soluble in water, DMSO, methanol. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Usta IM, Khalil A, Nassar AH. Oxytocin antagonists for the management of preterm birth: a review. Am J Perinatol. 2011 Jun;28(6):449-60. PMID: 21170825.
Pierzynski P. Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction. Reprod Biomed Online. 2011 Jan;22(1):9-16. PMID: 21130036.
Nucleoside (cytidine) analog; DNMT inhibitor, p...
Triterpenoid
Peptide, involved in synapse formation and cell...
Roscovitine analog; CDK inhibitor.
Peptide fragment of HER2/neu/erbB2 receptor.
Peptide, vSrc-induced cytokine.
Selective HDAC4 and HDAC5 inhibitor.
PAK inhibitor.Smo inhibitor.
Terpene found in the rind of various citrus fru...
Peptide, binds heparin.
NSAID; COX-2 inhibitor.
SERT, NET, MAO inhibitor.
Endogenous peptide hormone, glugagon fragment; ...
Calcium channel blocker.
GABA-A antagonist.
Renin inhibitor.
KRAS inhibitor
Fluoroquinolone; topoisomerase IV and bacterial...
PIKfyve inhibitor.
Sesquiterpene lactone derived from Artemesia; m...